CB
Cardiac Biotech Solutions Inc.
CBSC · OTC
$0.04 +0.00% (+$0.00)
1M -3.85%
Market Cap $5.79M
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 39.17x
EV/EBITDA N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 578.04%
Op. margin 725.51%
FCF margin 465.07%
Quality
62 /100
Average ROA 169.08%
Asset turnover 0.29x
ROIC 94.18%
Debt
0 /100
High Int. coverage -6.24x
Current ratio 0.23x
Net debt/EBITDA N/A
Stability
0 /100
Unstable Beta 1.93x
EPS volatility N/A
Profitable years N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CBSC
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Charles K. Martin
Employees
4
Headquarters
Las Vegas